Home › NDC Lookup › RxCUI directory › RxCUI 861672

1 ML dihydroergotamine mesylate 1 MG/ML Injection — RxCUI 861672

Name: 1 ML dihydroergotamine mesylate 1 MG/ML Injection (RxCUI 861672)
Creator: Brian Staiger, PharmD

RxNorm drug concept · Semantic clinical drug

RxCUI 861672 Semantic clinical drug · SCD ● Current RxNorm concept 6 FDA products 8 package NDCs Snapshot Jul 14, 2026

This page is curated, coded, and maintained by Dr. Brian Staiger, PharmD

Compiled from public NLM RxNorm and FDA (openFDA NDC directory) data sources. Editorial policy

What you’re looking at: the standardized identity of one medicine, as the U.S. drug-data system sees it. Below — every FDA-listed product, package code, price benchmark, and billing code that maps to it.

🗂️ Key Facts

RxCUI861672

Official name1 ML dihydroergotamine mesylate 1 MG/ML Injection

Concept typeSemantic clinical drug (SCD)

RxNorm statusCurrent RxNorm concept

Also known as1 ML DHE Mesylate 1 MG/ML Injection; dihydroergotamine mesylate 1 MG in 1 ML Injection; dihydroergotamine mesylate 1 MG per 1 ML Injection

FDA products mapped6

Package NDCs mapped8

Reported Medicaid activity (SDUD)201 prescriptions · 4 state & territory Medicaid programs · latest period Q4 2025

RxNorm release07/06/2026

Snapshot dataJul 14, 2026

📖 Skip the Codes — Read It in Plain English.

Our pharmacist-built guide to Dihydroergotamine Injection: what it is, how it’s used, side effects, and interactions.

📗 Our plain-language guide HelloPharmacist

It works by activating certain serotonin receptors in the brain, which helps shrink swollen blood vessels and block pain signals from your trigeminal nerve — the nerve network resp...
What exactly does this injection do for my migraine?
Brekiya is injected just under the skin of your middle thigh. Remove the red needle cap, press the device firmly against a clean area of skin, then push and release the gray activa...
How do I use the Brekiya autoinjector at home?

📖 Read our full Dihydroergotamine Injection guide →

🕸️ Concept Web — How 1 ML dihydroergotamine mesylate 1 MG/ML Injectio... Connects

One RxCUI never lives alone. Follow the path from the raw ingredient down to the exact strength-and-form concepts FDA products carry — every stop is a real RxNorm concept with its own identifier. Hover or focus any chip for what it means.

This page's concept 1 ML dihydroergotamine mesylate 1 MG/ML Injection RxCUI 861672 Semantic clinical drug · SCD

Every web starts here: one RxCUI, one fixed meaning in the RxNorm vocabulary.

Ingredients 2

The active substance itself — no strength, form, or brand attached yet.
- Dihydroergotamine 3418 IN
- Dihydroergotamine mesylate 203176 PIN
Dose forms 6

The ingredient poured into a form — tablet, solution, cream — still without one fixed strength.
- Dihydroergotamine Injection 1860094 SCDF
- Dihydroergotamine mesylate Injection 2646036 SCDFP
- Dihydroergotamine Injectable Product 1151868 SCDG
- Dihydroergotamine mesylate Injectable Product 2660086 SCDGP
- Injection 1649574 DF
- Injectable Product 1151126 DFG
Clinical & branded drugs 1

Ingredient + strength + dose form. These are the concepts real FDA products actually carry.
- Dihydroergotamine mesylate 1 MG/ML 861671 SCDC

Showing up to 8 concepts per family — 9 of 9 stored related concepts drawn.

These are official RxNorm vocabulary relationships — how concepts name and organize the same medicine. They do not establish therapeutic equivalence or substitutability: two concepts appearing in one web is never a statement that products can be swapped.

🔀 Generic ⇄ Brand Crosswalk

The same medicine has an unbranded (generic) identity and one or more brand-name identities — each with its own RxCUI. This is a naming relationship in RxNorm, not a statement that any two products are substitutable.

Generic (Clinical) Concepts

Dihydroergotamine mesylate 1 MG/ML SCDC · 861671
Dihydroergotamine Injection SCDF · 1860094
Dihydroergotamine mesylate Injection SCDFP · 2646036
Dihydroergotamine Injectable Product SCDG · 1151868
Dihydroergotamine mesylate Injectable Product SCDGP · 2660086

📦 FDA Products & Package NDCs

6 products · 8 package NDCs

8 package NDCs map to RxCUI 861672 in the current snapshot — up to 50 per page. Each linked NDC opens its full package page.

Package NDC	Package	Brand / generic name	Labeler	Marketing start
00143-9151-10	10 VIAL in 1 CARTON (0143-9151-10) / 1 mL in 1 VIAL	Dihydroergotamine Mesylate	Hikma Pharmaceuticals USA Inc.	2023-03-31
00143-9273-10	10 AMPULE in 1 CARTON (0143-9273-10) / 1 mL in 1 AMPULE (01...	Dihydroergotamine Mesylate	Hikma Pharmaceuticals USA Inc.	2017-09-15
36000-0300-10	10 AMPULE in 1 CARTON (36000-300-10) / 1 mL in 1 AMPULE (36...	dihydroergotamine mesylate	Baxter Healthcare Corporation	2025-01-07
68083-0466-10	10 AMPULE in 1 CARTON (68083-466-10) / 1 mL in 1 AMPULE	Dihydroergotamine Mesylate	Gland Pharma Limited	2023-08-18
71357-0013-05	5 AMPULE in 1 CARTON (71357-013-05) / 1 mL in 1 AMPULE (713...	Dihydroergotamine Mesylate	Milla Pharmaceuticals Inc.	2026-05-22
71357-0013-10	10 AMPULE in 1 CARTON (71357-013-10) / 1 mL in 1 AMPULE (71...	Dihydroergotamine Mesylate	Milla Pharmaceuticals Inc.	2026-05-22
81284-0411-05	5 AMPULE in 1 CARTON (81284-411-05) / 1 mL in 1 AMPULE (812...	Dihydroergotamine Mesylate	Provepharm Inc.	2021-09-30
81284-0411-10	10 AMPULE in 1 CARTON (81284-411-10) / 1 mL in 1 AMPULE (81...	Dihydroergotamine Mesylate	Provepharm Inc.	2021-09-30

Observed labelers: Hikma Pharmaceuticals USA Inc. (2) · Milla Pharmaceuticals Inc. (2) · Provepharm Inc. (2) · Baxter Healthcare Corporation (1) · Gland Pharma Limited (1) — this is the FDA-listed mapping footprint, not sales, inventory, availability, or market share.

🧾 Billing Codes (HCPCS)

Medical billing codes (HCPCS "J-codes") that connect to this concept's packages — used mostly when a clinic or hospital bills for a drug it administers. Each code links to its full billing page.

Code	Descriptor	Mapped packages	Sources
J1110	Inj dihydroergotamine mesylt	3	CMS

⚠ A crosswalk is not coverage: an NDC↔HCPCS mapping does not guarantee any payer covers or pays the code. Always verify the current payer policy before billing.

🗃️ Sources & Limits

Atlas generation902fddb9-e9c1-4004-bf4c-dba4d51037c7

openFDA export observedJul 14, 2026

RxNorm release07/06/2026

Methodology2026-07-full-catalog-v1

A shared RxCUI does not prove interchangeability. Products mapped to the same concept are not thereby equivalent or substitutable — equivalence is a separate, product-level determination.
Listing here does not establish approval or coverage. Appearing in this snapshot is a data observation, not an FDA approval status or a payer coverage decision.
Missing data never means zero. A silent dataset (no price, no billing code, no utilization) means no observation — not that the real-world value is zero.
Counts describe the mapping footprint. Product, package, and labeler counts are the FDA-listed mapping footprint in this snapshot — not sales, inventory, availability, or market share.

This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.

Machine-readable JSON

Reference information about drug-concept identifiers and public regulatory data — not medical advice. Talk to your pharmacist or prescriber about your own medication.